Table 1.
Characteristics of systemic lupus erythematosus (SLE) patients and control subjects.
| SLE | Control | |
|---|---|---|
| Number | 32 | 24 |
| Sex (female/male) | 32/0 | 24/0 |
| SLEDAI score mean ± s.d. | 9.3 ± 3.9 | n.a |
| Anti-dsDNA titre mean ± s.d. (IU/mL) | 121.2 ± 86.1 | n.a |
| Patients with nephritis (%) | (17/32) 53% | n.a |
| Treatment with prednisolone | ||
| Patients, number (%) | 93.75% | n.a |
| Treatment with hydroxychloroquine | ||
| Patients, no. (%) | 87.5% | n.a |
| Treatment with azathioprine | ||
| Patients, no. (%) | 0% | n.a |
Values are in mean ± standard deviation (s.d.); n.a.: not applicable.